The PICO method in clinical research

Why the research question is the cornerstone of a protocol

A clinical research protocol can be methodologically rigorous, statistically well powered and regulatorily compliant — and yet still fail to convince a scientific committee or a funder if the initial research question is vague, too broad or poorly delineated.

The research question is not an introductory formality. It is the starting point for all the methodological decisions that follow: the choice of study design, the definition of the population, the selection of endpoints, the sample size calculation. A poorly framed question generates costly back-and-forth with the methodology teams and the clinical research offices (DRCI), and significantly delays project submission.

The PICO method is today the reference tool for structuring this question in a rigorous and communicable way.

What is the PICO method?

PICO is a structuring acronym that breaks the research question down into four dimensions:

• P — Population: what is the study's target population? What criteria define it (pathology, age, disease stage, care setting)?
• I — Intervention: what is the intervention under study? It may be a drug treatment, a medical device, a procedure, a care strategy or an exposure.
• C — Comparator: what is the intervention compared with? Placebo, standard-of-care treatment, no intervention, or another therapeutic strategy.
• O — Outcome (endpoint): what is the result measured to assess the efficacy or safety of the intervention?

The PICO method derives from the founding work of Evidence-Based Medicine (EBM) and has progressively become the standard for drafting clinical research questions, particularly for interventional studies.

Variations of PICO according to study type

The original PICO framework has been extended to adapt to more complex study contexts.

PICO-T: incorporating time

The T adds the temporal dimension: over what duration is the outcome measured? This precision is particularly important for survival studies, prospective cohort studies or trials with prolonged follow-up.

Example: in patients with moderate to severe COPD (P), does adding a long-acting bronchodilator (I) compared with standard monotherapy (C) reduce the exacerbation rate (O) over 12 months (T)?

PICO-S: specifying the context

The S (Setting or Study design) is useful when the study's setting directly affects the generalizability of the results: primary care vs hospital care, resource-limited countries, private practice vs university hospital (CHU).

PICO adapted to observational studies

For observational studies (cohorts, case-control), the C may denote a non-exposed comparison group, and the I becomes an E (Exposure). This is sometimes referred to as the PECO framework (Population, Exposure, Comparator, Outcome).

Common errors in applying the PICO method

1. A population that is too broad

Defining the population as "hospitalized adult patients" without specifying the pathology, the stage or the care setting makes the question impossible to operationalize. Each letter of PICO must be precise enough to allow the inclusion and exclusion criteria to be drafted.

2. A non-measurable outcome

The outcome must be measurable, defined in time, and clinically relevant. "Improvement in quality of life" is not an endpoint — "EQ-5D-5L score at 6 months" is one.

3. Confusing the intervention with the objective

The intervention describes what is done; the outcome describes what one hopes to measure. These two dimensions are often confused in the early versions of a project, which produces circular protocols.

4. Omitting the comparator in a trial

In a randomized trial, the absence of a clearly defined comparator weakens the entire design. Even when the study is single-arm (feasibility study, phase I/II), the question of the implicit comparator must be addressed.

From the PICO method to drafting the protocol

Once the research question is structured according to PICO, the subsequent methodological steps follow logically:

• The P governs the inclusion and exclusion criteria, and guides thinking on recruitment feasibility.
• The I and the C determine the study design (randomized trial, non-randomized comparative study, cohort study).
• The primary O becomes the primary endpoint, from which the sample size is calculated.
• The whole PICO structure is carried over into the scientific justification of the synopsis submitted to the DRCI.

The PICO method is therefore not merely a formulation tool — it is a tool for the internal consistency of the protocol.

In summary

Mastering the PICO method means laying the foundations of a research project that is communicable, assessable and defensible before a scientific committee or a funder. It is also the starting point for an effective literature review and a relevant analysis of existing trials.